Antitumor agents - protein kinase inhibitors :: Description of the pharmacological group, drugs

Pharmaceutical group drugs

Substance	Drugs
Abemaciclib	Verzenio \| Зенлистик
Afatinib	Giotrif
Akalabrutinib	Калквенс
Alectinib	Alecensa
Asciminib	Сцембликс
Axitinib	Inlyta
Binimetinib	Мектови
Bosutinib	Bosulif \| Бозутиниб
Cabozantinib	Кабометикс
Capmatinib	Табректа
Ceritinib	Zykadia
Cobimetinib	Cotellic
Crizotinib	Xalkori
Dabrafenib	Rafinlar \| Tafinlar
Dacomitinib	Визимпро
Dasatinib	Dasatinib-nativ \| Sprycel \| Дазатиниб \| Дазатиниб-ТЛ \| Мирсониб
Duvelisib	Копиктра
Encorafenib	Брафтови
Entrectinib	Розлитрек
Erlotinib	Erlotinib \| Erlotinib - native \| Erlotinib hydrochloride \| Tarceva \| Tarlenib \| Эрлатера \| Эрлотиниб-тл
Everolimus	Afinitor \| Everolimus \| Sertican \| Амеверол \| Николимус \| Олирамус \| ПАФТОРН \| Эверолимус-промомед
Gefitinib	Gefitinib \| Gefitinib-TL \| Gefitinib-nativ \| Iressa \| ВАЛКИРА \| ГЕТИНЕКС \| Гефиба онко \| Гефитиниб Канон \| Гефитиниб-Рус \| Гефитиниб-промомед \| Гефтесса \| ЛАНГОТЕР \| Лангерра
Gilteritinib	Ксоспата
Ibrutinib	Imbruvica
Imatinib	Citonib \| Genfatinib \| Gistamel \| Glivec \| Iimatinib mesilate \| Imagliv \| Imatib \| Imatinib \| Imatinib Dr. Reddy s \| Imatinib Grindex \| Imatinib medac \| Imatinib-Actavis \| Imatinib-Alvogen \| Imatinib-TL \| Imatinib-Teva \| Imvec \| Neopax \| Philachromin \| Philachromin FS \| Албитиниб \| Глемихиб \| Иглиб \| Иматиниб-Сигардис \| Цитонибонко
Ixazomib	Ninlaro \| Иксазомиба цитрат
Lapatinib	Tyverb \| Лапатиниб-химрар \| Лапатиниба дитозилат моногидрат
Larotrectinib	Витракви
Lenvatinib	Lenvatinib \| Lenvima
Lorlatinib	Лорвиква
Midostaurin	Митикайд
Nilotinib	Nilotinib hydrochloride monohydrate \| Nilotinib-nativ \| Tasigna \| Нилотиниб
Nintedanib	Vargatef
Osimertinib	Tagrisso \| Осимертиниб \| Осимертиниба мезилат
Palbociclib	Ibrance \| Итулси
Pazopanib	Pazopanib \| Pazopanib-TL \| Votrient \| Амезопан \| ПОТАРБИН \| Пазопаниба гидрохлорид
Ponatinib	Айклусиг
Regorafenib	Stivarga
Ribociklib	Kisqali \| Risarg
Ruxolitinib	Jaakafi
Selumetinib	Коселуго
Sorafenib	Nexavar \| Sorafenib \| Сорафениб геми-тозилат моногидрат \| Сорафениб-АМЕДАРТ \| Сорафениб-натив \| Сорафениб-промомед \| Сорафениба тозилат \| Флутриксан
Sunitinib	Sunitinib \| Sunitinib-nativ \| Sutent \| Валеотиниб \| Сунитиниб-промомед \| Сунитиниба малат
Temsirolimus	Torizel
Trametinib	Mekinist
Vandetanib	Caprelsa
Vemurafenib	Zelboraf
Zanubrutinib	Брукинза
The active substance is not described	Tafinlar Combo

Tree of pharmacological groups

Antitumor agents

Antitumor agents - protein kinase inhibitors (Selected)
✚ Alkylating agents
✚ Antimetabolites
✚ Antitumor agents - monoclonal antibodies
✚ Antitumor agents of plant origin
✚ Antitumor antibiotics
Antitumor hormonal agents and hormone antagonists
Other antitumor agents

Description

There is no detailed description, see related

✘Available only when using PRO account

Content moderator: Vasin A. S.

Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
Nothing in the information provided should be interpreted as a call to use these drugs.
No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.